Ipidacrinum 20mg 20-50 tablets

Composition:
active substance: ipidacrine; 1 tablet contains ipidacrine hydrochloride 20 mg; excipients: lactose, monohydrate; potato starch; calcium stearate.

Pharmacotherapeutic group:
Means acting on the nervous system. Parasympathomimetics. Anticholinesterase drugs. PBX code N07A A.

Indication:
– Diseases of the peripheral nervous system (neuropathies, neuritis, polyneuritis and polyneuropathies, myelopolyradiculoneuritis); – myasthenia and myasthenic syndrome; – bulbar paralysis and paresis; – memory impairment of various etiologies (Alzheimer’s disease and other forms of senile impairment of mental activity); mental retardation in children; – the recovery period of organic lesions of the central nervous system accompanied by movement disorders; – in complex therapy of multiple sclerosis and other forms of demyelinating diseases of the nervous system; – intestinal atony.